Home Stock

Stock Research: COSMOS Pharmaceutical

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

COSMOS Pharmaceutical

TYO:3349 JP3298400007
44
  • Value
    39
  • Growth
    31
  • Safety
    Safety
    61
  • Combined
    37
  • Sentiment
    54
  • 360° View
    360° View
    44
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

COSMOS Pharmaceutical Corporation operates drug stores, offering medical goods, cosmetics, and general food products. In the last fiscal year, the company had a market cap of $4962 millions, profits of $1481 millions, and revenue of $7022 millions.

more

ANALYSIS: With an Obermatt 360° View of 44 (better than 44% compared with alternatives), overall professional sentiment and financial characteristics for the stock COSMOS Pharmaceutical are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half below and half above average for COSMOS Pharmaceutical. The consolidated Sentiment Rank has a good rank of 54, which means that professional investors are more optimistic about the stock than for 54% of alternative investment opportunities. It also rates well regarding its financing structure, with the consolidated Safety Rank at 61 or better than 61% of its peers when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the stock is expensive and expects low growth. The consolidated Value Rank is only 39, meaning that the share price of COSMOS Pharmaceutical is on the high side, compared with indicators such as revenues, profits, and invested capital. The company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, invested capital growth,and stock returns, with its Growth Rank at 31. ...read more

more
Strongest Rank Stock Returns
Weakest Rank Liquidity
Country Japan
Industry Drug Retail
Size Large
Website cosmospc.co.jp
Index
COSMOS Pharmaceutical stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Jul-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
39 31 23 17
Growth
31 69 51 75
Safety
Safety
61 55 69 67
Sentiment
54 91 49 45
360° View
360° View
44 79 42 50
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
58 57 29 29
Opinions Change
39 62 39 50
Pro Holdings
n/a 83 67 49
Market Pulse
30 71 75 65
Sentiment
54 91 49 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
39 31 23 17
Growth
31 69 51 75
Safety Safety
61 55 69 67
Combined
37 50 37 49
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
46 48 43 38
Price vs. Earnings (P/E)
49 41 27 29
Price vs. Book (P/B)
45 43 39 36
Dividend Yield
33 25 18 14
Value
39 31 23 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
68 70 70 65
Profit Growth
53 69 26 21
Capital Growth
44 48 44 55
Stock Returns
15 29 67 71
Growth
31 69 51 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
57 75 82 86
Refinancing
17 11 24 24
Liquidity
75 79 90 90
Safety Safety
61 55 69 67

Similar Stocks

Discover high‑ranked alternatives to COSMOS Pharmaceutical and broaden your portfolio horizons.

Kinden

TYO:1944
Country: Japan
Industry: Construction & Engineering
Size: X-Large
Full Stock Analysis

ANA

TYO:9202
Country: Japan
Industry: Airlines
Size: X-Large
Full Stock Analysis

Toyobo

TYO:3101
Country: Japan
Industry: Commodity Chemicals
Size: Large
Full Stock Analysis

Ushio

TYO:6925
Country: Japan
Industry: Electr. Components & Equipment
Size: Large
Full Stock Analysis

Frequently Asked
Questions

The value case is weak (expensive and low Growth Rank), but sentiment is strong and financing is safe. This scenario may indicate future growth not yet in current financials. This is a speculative choice for investors with a high-risk appetite who are betting on the positive sentiment and safe financing to sustain a long-term turnaround.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews